Ejector
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 8, 2020
Grant Date -
Feb 7, 2019
app pub date -
Jan 24, 2017
filing date -
Feb 2, 2016
priority date (Note) -
In Force
status (Latency Note)
![]() |
A preliminary load of PAIR data current through [] has been loaded. Any more recent PAIR data will be loaded within twenty-four hours. |
PAIR data current through []
A preliminary load of cached data will be loaded soon.
Any more recent PAIR data will be loaded within twenty-four hours.
![]() |
Next PAIR Update Scheduled on [ ] |

Importance

US Family Size
|
Non-US Coverage
|
Abstract
An ejector includes a body including an inflow space into which a refrigerant flows, a passage formation member disposed inside the body and having a conical shape, and a nozzle passage having an annular cross section functioning as a nozzle and a diffuser passage having an annular cross section functioning as a pressurizing portion between an inner wall surface of the body and a conical lateral surface of the passage formation member. A drive mechanism that displaces the passage formation member along a center axis is coupled to an upstream actuating bar which extends from the passage formation member toward the inflow space and is slidably supported by the body. A largest outer diameter portion of an annular member forming a wall surface of the nozzle passage provides a throat portion functioning as an edge for enlarging a passage cross-sectional area to cause a separation vortex in the refrigerant.
First Claim
all claims..Other Claims data not available
Family

- 15 United States
- 10 France
- 8 Japan
- 7 China
- 5 Korea
- 2 Other
Patent Owner(s)
Patent Owner | Address | |
---|---|---|
DENSO CORPORATION | 1-1 SHOWA-CHO KARIYA-CITY AICHI 4488661 ?4488661 |
International Classification(s)

- 2017 Application Filing Year
- F25B Class
- 1295 Applications Filed
- 923 Patents Issued To-Date
- 71.28 % Issued To-Date
Inventor(s)
Inventor Name | Address | # of filed Patents | Total Citations |
---|---|---|---|
Nagano, Yohei | Kariya, JP | 4 | 9 |
# of filed Patents : 4 Total Citations : 9 | |||
Nakashima, Ryota | Kariya, JP | 18 | 52 |
# of filed Patents : 18 Total Citations : 52 | |||
Nishijima, Haruyuki | Kariya, JP | 83 | 869 |
# of filed Patents : 83 Total Citations : 869 | |||
Oshitani, Hiroshi | Kariya, JP | 56 | 929 |
# of filed Patents : 56 Total Citations : 929 | |||
Takano, Yoshiaki | Kariya, JP | 134 | 2177 |
# of filed Patents : 134 Total Citations : 2177 | |||
Yokoyama, Yoshiyuki | Kariya, JP | 43 | 479 |
# of filed Patents : 43 Total Citations : 479 |
Cited Art Landscape
- No Cited Art to Display

Patent Citation Ranking
- 2 Citation Count
- F25B Class
- 62.37 % this patent is cited more than
- 5 Age
Forward Cite Landscape
- No Forward Cites to Display

Maintenance Fees
Fee | Large entity fee | small entity fee | micro entity fee | due date |
---|---|---|---|---|
7.5 Year Payment | $3600.00 | $1800.00 | $900.00 | Mar 8, 2028 |
11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Mar 8, 2032 |
Fee | Large entity fee | small entity fee | micro entity fee |
---|---|---|---|
Surcharge - 7.5 year - Late payment within 6 months | $160.00 | $80.00 | $40.00 |
Surcharge - 11.5 year - Late payment within 6 months | $160.00 | $80.00 | $40.00 |
Surcharge after expiration - Late payment is unavoidable | $700.00 | $350.00 | $175.00 |
Surcharge after expiration - Late payment is unintentional | $1,640.00 | $820.00 | $410.00 |
Full Text
- i. providing a composition comprising one or more ribonucleic acids molecules (RNA),ii. hybridizing to said one or more RNAs, one or more two-part nucleic acid hybridization probes, wherein each probe comprises, a. a first nucleic acid molecule with a 3′-tail wherein said tail does not hybridize to an RNA in the composition,b. a second nucleic acid molecule with a 5′-tail wherein said tail does not hybridize to an RNA in the composition,c. wherein said first and said second nucleic acid molecules when and if hybridized to their target RNA lie on one single stranded RNA molecule separated from each other by between 2 and 1000 nucleotides, iii. covalently linking the hybridized 5′-tail of said first nucleic acid molecule to the hybridized 3′-tail of said second nucleic acid, wherein the linking is done by means of reverse transcription and subsequent ligation,iv. amplifying the linked molecules with primers that are specific for said first 3′-tail of said first nucleic acid molecule and said second 5′-tail of said second nucleic acid molecule and,v. sequencing the amplification products by means of next generation sequencing.

Legal Events
- No Legal Status data available.

Matter Detail

Renewals Detail
